106 related articles for article (PubMed ID: 8769113)
1. Regulation of fatty acid biosynthesis by intermediates of the cholesterol biosynthetic pathway.
Ku EC
Biochem Biophys Res Commun; 1996 Aug; 225(1):173-9. PubMed ID: 8769113
[TBL] [Abstract][Full Text] [Related]
2. Bifunctional inhibitors of mevalonate kinase and mevalonate 5-diphosphate decarboxylase.
Qiu Y; Li D
Org Lett; 2006 Mar; 8(6):1013-6. PubMed ID: 16524256
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the inhibition of cholesterol biosynthesis by 6-fluoromevalonate.
Nave JF; d'Orchymont H; Ducep JB; Piriou F; Jung MJ
Biochem J; 1985 Apr; 227(1):247-54. PubMed ID: 2986604
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1995 Apr; 55(8):1732-40. PubMed ID: 7712482
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
[TBL] [Abstract][Full Text] [Related]
6. Mutation and inhibition studies of mevalonate 5-diphosphate decarboxylase.
Qiu Y; Gao J; Guo F; Qiao Y; Li D
Bioorg Med Chem Lett; 2007 Nov; 17(22):6164-8. PubMed ID: 17888661
[TBL] [Abstract][Full Text] [Related]
7. Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2.
Polo MP; de Bravo MG
Biochem Cell Biol; 2006 Feb; 84(1):102-11. PubMed ID: 16462894
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin increases arachidonic acid levels and stimulates thromboxane synthesis in human liver and monocytic cell lines.
Hrboticky N; Tang L; Zimmer B; Lux I; Weber PC
J Clin Invest; 1994 Jan; 93(1):195-203. PubMed ID: 8282787
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
White LW
J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
[No Abstract] [Full Text] [Related]
11. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
[TBL] [Abstract][Full Text] [Related]
12. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
[TBL] [Abstract][Full Text] [Related]
13. Mevalonic acid analogs as inhibitors of cholesterol biosynthesis.
DeBold CR; Elwood JC
J Pharm Sci; 1981 Sep; 70(9):1007-10. PubMed ID: 6101142
[TBL] [Abstract][Full Text] [Related]
14. Effect of ethanol on cell growth and cholesterol metabolism in cultured Hep G2 cells.
Polo MP; de Bravo MG; de Alaniz MJ
Biochem Cell Biol; 2003 Dec; 81(6):379-86. PubMed ID: 14663504
[TBL] [Abstract][Full Text] [Related]
15. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
16. An alternative mechanism for the inhibition of cholesterol biosynthesis in HepG2 cells by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol (MDL 28,815).
Van Sickle WA; Wilson PK; Wannamaker MW; Cooper JR; Flanagan MA; McCarthy JR; Bey P; Jackson RL
J Pharmacol Exp Ther; 1993 Dec; 267(3):1243-9. PubMed ID: 8263786
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cholesterol biosynthesis by fluorinated mevalonate analogues.
Reardon JE; Abeles RH
Biochemistry; 1987 Jul; 26(15):4717-22. PubMed ID: 3663621
[TBL] [Abstract][Full Text] [Related]
18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
Hamadmad SN; Hohl RJ
Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts.
Gebhardt R
J Pharmacol Exp Ther; 1998 Sep; 286(3):1122-8. PubMed ID: 9732368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]